WASHINGTON (AP) — Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the COVID-19 pandemic upended factory ...
The FDA has issued a request for information (RFI) for advancing model-informed drug development (MIDD) to assist CDER and CBER in identifying and prioritizing potential focus areas for future policy ...
Those doses can be used in adults and children as young as 6 months. On Friday, the Food and Drug Administration gave the OK to the updated Novavax formula, too — and those shots are open to ...
Before locking in your 2024 Tour Championship picks or PGA props, be sure to see the golf predictions and projected leaderboard from the proven computer model at SportsLine. Our proprietary model ...
Our proprietary model, built by DFS pro Mike McClure, has been red-hot since the PGA Tour resumed in June 2020. In fact, the model is up more than $9,500 on its best bets since the restart ...
Research Triangle Park-based Atsena Therapeutics recently secured a Rare Pediatric Disease (RPD) designation from the U.S. Food and Drug Administration for its clinical-stage ocular gene therapy.
Currently anticipate patient enrollment to start in 4Q calendar year 2024 Topline results currently expected in 4Q calendar year 2025 CRANBURY, N.J., Aug. 28, 2024 /PRNewswire/ -- Palatin ...
Chinese electric vehicle (EV) maker Xpeng unveiled the first budget model under its new brand Mona on Tuesday, taking a step forward in making self-driving technology affordable to low and middle ...
After hitting a regulatory snare with its lead drug candidate earlier this year, ophthalmology specialist EyePoint Pharmaceuticals has run up against another spot of trouble with the FDA.
Ocugen has already received clearance from the FDA to initiate a phase III study on OCU400 for the treatment of RP, a rare genetic disorder that can lead to vision loss and blindness. The FDA had ...
Lagos, Nigeria — The Nigeria Police Force has made a significant breakthrough in an ongoing investigation into a complex case involving conspiracy, impersonation, hijacking, and drug trafficking.